CELH
Get informed when a big investor buys or sells
+ FollowUndervalued by 221.8% based on the discounted cash flow analysis.
| Market cap | $7.10 Billion |
|---|---|
| Enterprise Value | $7.21 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.25 |
| Beta | 0.93 |
| Outstanding Shares | 254,806,000 |
| P/E Ratio | 132.24 |
|---|---|
| PEG | -208.16 |
| Price to Sales | 2.62 |
| Price to Book Ratio | 2.62 |
| Enterprise Value to Revenue | 2.37 |
| Enterprise Value to EBIT | 41.11 |
| Enterprise Value to Net Income | 101 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.62 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2059▼ 37.36% |
|---|---|
| Total Calls | 2,715,800▼ 78.94% |
| Total Puts | 559,300▼ 92.52% |
Holdings and activity of institutional investors.
| Ownership % | 16.85%▼ 44.83% |
|---|---|
| Total Invested | $1.27B▼ 78.20% |
| Investors Holding | 261▼ 369.00% |
No data
Celsius Holdings, Inc., is a global company with a proprietary, clinically proven formula for its master brand CELSIUS® and all its sub-brands. A lifestyle fitness drink and a pioneer in the rapidly growing performance energy sector, CEL...